Classification of Coronary Magnetic Resonance Angiography (CMRA) CAD-RADS scores as compared with Coronary Computed Tomography Angiography (CCTA), along with sensitivity, specificity, NPV, PPV, and AUC for CAD-RADS threshold ≥ 1, ≥ 2, ≥ 3, and ≥4 on a per-patient basis
| Per-patient CAD-RADS analysis . | ||||||
|---|---|---|---|---|---|---|
| . | Classification agreement . | Sensitivity . | Specificity . | PPV . | NPV . | AUC . |
| CAD-RADS ≥ 1 | 0.80 (0.71–0.88) | 0.85 (0.76–0.92) | 0.46 (0.19–0.75) | 0.91 (0.82–0.96) | 0.33 (0.13–0.59) | 0.66 (0.51–0.80) |
| CAD-RADS ≥ 2 | 0.73 (0.63–0.81) | 0.75 (0.63–0.84) | 0.67 (0.45–0.84) | 0.87 (0.76–0.94) | 0.47 (0.30–0.65) | 0.71 (0.60–0.82) |
| CAD-RADS ≥ 3 | 0.63 (0.53–0.73) | 0.71 (0.56–0.83) | 0.55 (0.40–0.70) | 0.62 (0.48–0.75) | 0.65 (0.48–0.79) | 0.63 (0.53–0.73) |
| CAD-RADS ≥ 4 | 0.70 (0.59–0.79) | 0.68 (0.45–0.86) | 0.70 (0.58–0.80) | 0.41 (0.25–0.58) | 0.88 (0.77–0.95) | 0.69 (0.58–0.80) |
| Per-patient CAD-RADS analysis . | ||||||
|---|---|---|---|---|---|---|
| . | Classification agreement . | Sensitivity . | Specificity . | PPV . | NPV . | AUC . |
| CAD-RADS ≥ 1 | 0.80 (0.71–0.88) | 0.85 (0.76–0.92) | 0.46 (0.19–0.75) | 0.91 (0.82–0.96) | 0.33 (0.13–0.59) | 0.66 (0.51–0.80) |
| CAD-RADS ≥ 2 | 0.73 (0.63–0.81) | 0.75 (0.63–0.84) | 0.67 (0.45–0.84) | 0.87 (0.76–0.94) | 0.47 (0.30–0.65) | 0.71 (0.60–0.82) |
| CAD-RADS ≥ 3 | 0.63 (0.53–0.73) | 0.71 (0.56–0.83) | 0.55 (0.40–0.70) | 0.62 (0.48–0.75) | 0.65 (0.48–0.79) | 0.63 (0.53–0.73) |
| CAD-RADS ≥ 4 | 0.70 (0.59–0.79) | 0.68 (0.45–0.86) | 0.70 (0.58–0.80) | 0.41 (0.25–0.58) | 0.88 (0.77–0.95) | 0.69 (0.58–0.80) |
95% CIs are expressed in brackets.
AUC, area under the curve; CAD-RADS, Coronary Artery Disease-Reporting and Data System; NPV, negative predictive value; PPV, positive predictive value.
Classification of Coronary Magnetic Resonance Angiography (CMRA) CAD-RADS scores as compared with Coronary Computed Tomography Angiography (CCTA), along with sensitivity, specificity, NPV, PPV, and AUC for CAD-RADS threshold ≥ 1, ≥ 2, ≥ 3, and ≥4 on a per-patient basis
| Per-patient CAD-RADS analysis . | ||||||
|---|---|---|---|---|---|---|
| . | Classification agreement . | Sensitivity . | Specificity . | PPV . | NPV . | AUC . |
| CAD-RADS ≥ 1 | 0.80 (0.71–0.88) | 0.85 (0.76–0.92) | 0.46 (0.19–0.75) | 0.91 (0.82–0.96) | 0.33 (0.13–0.59) | 0.66 (0.51–0.80) |
| CAD-RADS ≥ 2 | 0.73 (0.63–0.81) | 0.75 (0.63–0.84) | 0.67 (0.45–0.84) | 0.87 (0.76–0.94) | 0.47 (0.30–0.65) | 0.71 (0.60–0.82) |
| CAD-RADS ≥ 3 | 0.63 (0.53–0.73) | 0.71 (0.56–0.83) | 0.55 (0.40–0.70) | 0.62 (0.48–0.75) | 0.65 (0.48–0.79) | 0.63 (0.53–0.73) |
| CAD-RADS ≥ 4 | 0.70 (0.59–0.79) | 0.68 (0.45–0.86) | 0.70 (0.58–0.80) | 0.41 (0.25–0.58) | 0.88 (0.77–0.95) | 0.69 (0.58–0.80) |
| Per-patient CAD-RADS analysis . | ||||||
|---|---|---|---|---|---|---|
| . | Classification agreement . | Sensitivity . | Specificity . | PPV . | NPV . | AUC . |
| CAD-RADS ≥ 1 | 0.80 (0.71–0.88) | 0.85 (0.76–0.92) | 0.46 (0.19–0.75) | 0.91 (0.82–0.96) | 0.33 (0.13–0.59) | 0.66 (0.51–0.80) |
| CAD-RADS ≥ 2 | 0.73 (0.63–0.81) | 0.75 (0.63–0.84) | 0.67 (0.45–0.84) | 0.87 (0.76–0.94) | 0.47 (0.30–0.65) | 0.71 (0.60–0.82) |
| CAD-RADS ≥ 3 | 0.63 (0.53–0.73) | 0.71 (0.56–0.83) | 0.55 (0.40–0.70) | 0.62 (0.48–0.75) | 0.65 (0.48–0.79) | 0.63 (0.53–0.73) |
| CAD-RADS ≥ 4 | 0.70 (0.59–0.79) | 0.68 (0.45–0.86) | 0.70 (0.58–0.80) | 0.41 (0.25–0.58) | 0.88 (0.77–0.95) | 0.69 (0.58–0.80) |
95% CIs are expressed in brackets.
AUC, area under the curve; CAD-RADS, Coronary Artery Disease-Reporting and Data System; NPV, negative predictive value; PPV, positive predictive value.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
